Cargando…

Bradyarrhythmias in Cardio-Oncology

The relationship between bradyarrhythmias and cancer therapies has not been well described but is increasingly recognized. There have been extensive advances in oncological pharmacotherapy, with several new classes of drugs available including targeted agents, immune checkpoint inhibitors and CAR T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fonseca, Marta, Cheng, Evaline, Do, Duc, Haldar, Shouvik, Kutty, Shelby, Yang, Eric H., Ghosh, Arjun K., Guha, Avirup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Thieme Medical and Scientific Publishers Private Ltd 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8710146/ https://www.ncbi.nlm.nih.gov/pubmed/34966697 http://dx.doi.org/10.1055/s-0041-1731907

Ejemplares similares

Cardio‐Oncology in the Era of the COVID‐19 Pandemic and Beyond
por: Addison, Daniel, et al.
Publicado: (2020)

Editorial: Cancer treatment-related cardiovascular disease - real world data in cardio-oncology
por: Agarwala, Vivek, et al.
Publicado: (2023)

Implementation of Cardio-Oncology Training for Cardiology Fellows
por: Tuzovic, Mirela, et al.
Publicado: (2020)

Cardiac Tumors: JACC CardioOncology State-of-the-Art Review
por: Tyebally, Sara, et al.
Publicado: (2020)

Developing a Clinical Cardio-Oncology Program and the Building Blocks for Success: JACC: CardioOncology How To
por: Fradley, Michael G., et al.
Publicado: (2023)

Innovation in Precision Cardio-Oncology During the Coronavirus Pandemic and Into a Post-pandemic World
por: Brown, Sherry-Ann, et al.
Publicado: (2020)

Cardio oncology: Digital innovations, precision medicine and health equity
por: Sadler, Diego, et al.
Publicado: (2022)

#JACCCardioOnc: Evolution of a Dedicated Social Media Strategy for JACC: CardioOncology
por: Brown, Sherry-Ann, et al.
Publicado: (2021)

Artificial intelligence and imaging: Opportunities in cardio-oncology
por: Madan, Nidhi, et al.
Publicado: (2022)

Cardio-Oncology – A new subspecialty with collaboration at its heart
por: Ghosh, Arjun K., et al.
Publicado: (2017)

Ticagrelor-Induced Syncope/Bradyarrhythmia
por: Kotaru, VeeraPavan, et al.
Publicado: (2021)

Cardiac lymphoma presenting as bradyarrhythmia
por: Sanders, Mason, et al.
Publicado: (2022)

Cardiac Computed Tomography in Cardio-Oncology: JACC: CardioOncology Primer
por: Lopez-Mattei, Juan C., et al.
Publicado: (2021)

The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
por: Cheng, Richard K., et al.
Publicado: (2022)

Bradyarrhythmia in COVID-19 Patients
por: Hakami, Abdulrahman, et al.
Publicado: (2021)

Evaluation and Management of Asymptomatic Bradyarrhythmias
por: Çinier, Göksel, et al.
Publicado: (2021)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Future bradyarrhythmia in patients with hypertrophic cardiomyopathy
por: Nakasuka, Kosuke, et al.
Publicado: (2021)

BRADYARRHYTHMIAS AND MORTALITY IN COVID-19 PATIENTS
por: Hoang, Lawrence, et al.
Publicado: (2021)

Tachyarrhythmias, bradyarrhythmias and acute coronary syndromes
por: Trappe, Hans-Joachim
Publicado: (2010)

Violent Hiccups: An Infrequent Cause of Bradyarrhythmias
por: Suh, William M., et al.
Publicado: (2009)

Life-threatening bradyarrhythmia with oral phenytoin overdose
por: Srinivasan, Giridharan, et al.
Publicado: (2015)

Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
por: Liang, Zehua, et al.
Publicado: (2022)

Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building
por: Sadler, Diego, et al.
Publicado: (2021)

Bradyarrhythmias secondary to topical levobunolol hydrochloride solution
por: Lin, Lianjun, et al.
Publicado: (2014)

Phenytoin induced sinoatrial bradyarrhythmia in the perioperative period
por: Kakkar, Aanchal, et al.
Publicado: (2013)

Inherited bradyarrhythmia: A diverse genetic background
por: Ishikawa, Taisuke, et al.
Publicado: (2016)

Translational implications of bradyarrhythmia in hibernating brown bears
por: Gottlieb, Lisa A., et al.
Publicado: (2023)

Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
por: Albini, Adriana, et al.
Publicado: (2010)

Traditional Chinese Medicine for Bradyarrhythmia: Evidence and Potential Mechanisms
por: Liu, Shuo, et al.
Publicado: (2018)

Bradyarrhythmias in patients with COVID-19: A case series
por: Gupta, Mohit D., et al.
Publicado: (2020)

Cardio-Oncology in Iran
por: Alizadehasl, Azin, et al.
Publicado: (2021)

Cardio-oncology in 2022
por: Dobson, Rebecca
Publicado: (2023)

Incorporating Exercise Training into Cardio-Oncology Care: Current Evidence and Opportunities: JACC: CardioOncology State-of-the-Art Review
por: Wilson, Rebekah L., et al.
Publicado: (2023)

Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
por: Liu, Victor Y., et al.
Publicado: (2018)

Hypertension management in cardio-oncology
por: Essa, Hani, et al.
Publicado: (2020)

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology
por: Abdelgawad, Ibrahim Y., et al.
Publicado: (2019)

Cardioneuroablation for treating functional bradyarrhythmias. How much is enough?
por: Pachon-M, J.C., et al.
Publicado: (2021)

COVID‐19 induced bradyarrhythmia and relative bradycardia: An overview
por: Douedi, Steven, et al.
Publicado: (2021)

Bradyarrhythmias: First Presentation of Arrhythmogenic Right Ventricular Cardiomyopathy?
por: Burghouwt, Danielle E, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vftpg9bgt69vqiangd3rfu2vs6